Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Diagnosis and the current trends in multiple myeloma therapy.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Dmoszyńska A;Dmoszyńska A
- Source:
Polskie Archiwum Medycyny Wewnetrznej [Pol Arch Med Wewn] 2008 Oct; Vol. 118 (10), pp. 563-6.
- Publication Type:
Journal Article; Review
- Language:
English
- Additional Information
- Source:
Publisher: Medycyna Praktyczna Country of Publication: Poland NLM ID: 0401225 Publication Model: Print Cited Medium: Print NLM ISO Abbreviation: Pol Arch Med Wewn Subsets: MEDLINE
- Publication Information:
Publication: Krakow : Medycyna Praktyczna
Original Publication: Warszawa : Państwowy Zakład Wydawnictw Lekarskich
- Subject Terms:
- Abstract:
Multiple myeloma is still an incurable disease. In recent years the introduction of 3 novel drugs oriented on basic mechanisms of multiple myeloma cells proliferation and survival has improved patients' outcome. These drugs are: thalidomide, its new analog, lenalidomide, and proteasome inhibitor, bortezomib. All three are highly effective both in newly diagnosed and relapsed/resistant patients.
- Number of References:
19
- Accession Number:
0 (Antineoplastic Agents)
0 (Boronic Acids)
0 (Protease Inhibitors)
0 (Pyrazines)
4Z8R6ORS6L (Thalidomide)
69G8BD63PP (Bortezomib)
F0P408N6V4 (Lenalidomide)
- Publication Date:
Date Created: 20081231 Date Completed: 20090122 Latest Revision: 20181201
- Publication Date:
20240829
- Accession Number:
19112817
No Comments.